FP20 Which medium for endoscopic ultrasound fine-needle biopsy of pancreatic masses? A prospective crossover study of formalin versus liquid-based cytology ...

Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

Revolution Medicines' daraxonrasib receives FDA Breakthrough Therapy Designation for treating metastatic pancreatic cancer with specific KRAS mutations.

MRI-based screening has the potential for identifying early-stage pancreatic cancer in older adults with new onset or deteriorating diabetes, preliminary results show.

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study ...

Antiparasitic drugs such as fenbendazole have caught the attention of researchers studying pancreatic cancer. Here's what early research shows.

Around 50% of people with pancreatic adenocarcinoma — the most common type of pancreatic cancer — experience painless jaundice.

This report documents a fourth type of humoral activity, that of hyperglucagonism, associated with an alpha-cell carcinoma of the pancreatic islets.

The FDA has granted fast track designation to nadunolimab for use in combination with gemcitabine and nab-paclitaxel to treat patients with previously untreated, metastatic PDAC with high IL1RAP ...

Endosomal/Lysosomal pH-Sensitive Polymeric Nanoparticles for Active Intracellular DOX Delivery Polymeric nanoparticles are usually internalized by cancer cells via endocytosis. Following ...

Pancreatic ductal adenocarcinoma (PDAC) has long been considered to arise from pancreatic ducts on the basis of its morphology, the occurrence of dysplasia in putative preneoplastic ductal lesions, ...